FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897592075> ?p ?o ?g. }

• W2897592075 endingPage "1259" @default.
• W2897592075 startingPage "1250" @default.
• W2897592075 abstract "This systematic review evaluates the safety and efficacy of intravenous (IV) lidocaine for the treatment of acute pain in adult patients. The PubMed database was searched for randomized controlled trials, retrospective cohort studies, case series, and case reports evaluating the use of IV lidocaine for the treatment of acute pain in adult patients, published between January 1970 and January 2018. The primary outcome was pain reduction via the Visual Analog Scale, Verbal Rating Scale, or Numeric Rating Scale among patients treated with IV lidocaine and placebo or active controls. Safety outcomes included both nonserious and serious adverse events. A total of 347 titles and abstracts were screened, and after full-text review, 13 studies met the inclusion criteria involving 512 patients. The four active controls studied were IV morphine, IV ketorolac, IV dihydroergotamine (DHE), and IV chlorpromazine (CPZ). The dosing of IV lidocaine varied among studies between a weight-based dose of a 1- to 2-mg/kg bolus, a fixed-bolus dose of 50-100 mg, and a 1-mg/kg/hour continuous infusion. Monitoring of serum lidocaine concentrations was not done routinely. Intravenous lidocaine had superior efficacy to morphine for renal colic and critical limb ischemia, superior efficacy to DHE for acute migraine, and equivalent efficacy to ketorolac for acute radicular lower back pain. However, lidocaine was less effective than CPZ for the treatment of acute migraine. The most common adverse event reported among all studies were neurologic effects such as altered mental status and slurred speech. Due to the inconsistency in dosing, length of administration, and lack of serum monitoring, the absolute safety of IV lidocaine for acute pain is unknown. Larger, prospective studies are needed before the routine use of IV lidocaine can be recommended for all types of acute pain." @default.
• W2897592075 created "2018-10-26" @default.
• W2897592075 creator A5013791980 @default.
• W2897592075 creator A5030559353 @default.
• W2897592075 creator A5034479045 @default.
• W2897592075 creator A5053184375 @default.
• W2897592075 creator A5057380475 @default.
• W2897592075 creator A5086279999 @default.
• W2897592075 date "2018-11-09" @default.
• W2897592075 modified "2023-10-16" @default.
• W2897592075 title "Intravenous Lidocaine for Acute Pain: A Systematic Review" @default.
• W2897592075 cites W1797400911 @default.
• W2897592075 cites W1967881132 @default.
• W2897592075 cites W1973562006 @default.
• W2897592075 cites W1986369601 @default.
• W2897592075 cites W2001545310 @default.
• W2897592075 cites W2011051463 @default.
• W2897592075 cites W2021655399 @default.
• W2897592075 cites W2023170821 @default.
• W2897592075 cites W2034811230 @default.
• W2897592075 cites W2037847976 @default.
• W2897592075 cites W2043746432 @default.
• W2897592075 cites W2069726169 @default.
• W2897592075 cites W2081881541 @default.
• W2897592075 cites W2087559496 @default.
• W2897592075 cites W2098923148 @default.
• W2897592075 cites W2109837130 @default.
• W2897592075 cites W2135400982 @default.
• W2897592075 cites W2149658700 @default.
• W2897592075 cites W2156493342 @default.
• W2897592075 cites W2162638563 @default.
• W2897592075 cites W2292748019 @default.
• W2897592075 cites W2326692077 @default.
• W2897592075 cites W2341174219 @default.
• W2897592075 cites W2396931796 @default.
• W2897592075 cites W2523834085 @default.
• W2897592075 cites W2576440140 @default.
• W2897592075 cites W2586846979 @default.
• W2897592075 cites W4230531339 @default.
• W2897592075 cites W4248949355 @default.
• W2897592075 cites W4252510756 @default.
• W2897592075 doi "https://doi.org/10.1002/phar.2189" @default.
• W2897592075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30303542" @default.
• W2897592075 hasPublicationYear "2018" @default.
• W2897592075 type Work @default.
• W2897592075 sameAs 2897592075 @default.
• W2897592075 citedByCount "55" @default.
• W2897592075 countsByYear W28975920752019 @default.
• W2897592075 countsByYear W28975920752020 @default.
• W2897592075 countsByYear W28975920752021 @default.
• W2897592075 countsByYear W28975920752022 @default.
• W2897592075 countsByYear W28975920752023 @default.
• W2897592075 crossrefType "journal-article" @default.
• W2897592075 hasAuthorship W2897592075A5013791980 @default.
• W2897592075 hasAuthorship W2897592075A5030559353 @default.
• W2897592075 hasAuthorship W2897592075A5034479045 @default.
• W2897592075 hasAuthorship W2897592075A5053184375 @default.
• W2897592075 hasAuthorship W2897592075A5057380475 @default.
• W2897592075 hasAuthorship W2897592075A5086279999 @default.
• W2897592075 hasConcept C126322002 @default.
• W2897592075 hasConcept C141071460 @default.
• W2897592075 hasConcept C14184104 @default.
• W2897592075 hasConcept C142724271 @default.
• W2897592075 hasConcept C197934379 @default.
• W2897592075 hasConcept C204787440 @default.
• W2897592075 hasConcept C27081682 @default.
• W2897592075 hasConcept C2777288759 @default.
• W2897592075 hasConcept C2778446825 @default.
• W2897592075 hasConcept C2778541695 @default.
• W2897592075 hasConcept C2780149897 @default.
• W2897592075 hasConcept C2780820201 @default.
• W2897592075 hasConcept C2781302852 @default.
• W2897592075 hasConcept C42219234 @default.
• W2897592075 hasConcept C43376680 @default.
• W2897592075 hasConcept C71924100 @default.
• W2897592075 hasConceptScore W2897592075C126322002 @default.
• W2897592075 hasConceptScore W2897592075C141071460 @default.
• W2897592075 hasConceptScore W2897592075C14184104 @default.
• W2897592075 hasConceptScore W2897592075C142724271 @default.
• W2897592075 hasConceptScore W2897592075C197934379 @default.
• W2897592075 hasConceptScore W2897592075C204787440 @default.
• W2897592075 hasConceptScore W2897592075C27081682 @default.
• W2897592075 hasConceptScore W2897592075C2777288759 @default.
• W2897592075 hasConceptScore W2897592075C2778446825 @default.
• W2897592075 hasConceptScore W2897592075C2778541695 @default.
• W2897592075 hasConceptScore W2897592075C2780149897 @default.
• W2897592075 hasConceptScore W2897592075C2780820201 @default.
• W2897592075 hasConceptScore W2897592075C2781302852 @default.
• W2897592075 hasConceptScore W2897592075C42219234 @default.
• W2897592075 hasConceptScore W2897592075C43376680 @default.
• W2897592075 hasConceptScore W2897592075C71924100 @default.
• W2897592075 hasIssue "12" @default.
• W2897592075 hasLocation W28975920751 @default.
• W2897592075 hasLocation W28975920752 @default.
• W2897592075 hasOpenAccess W2897592075 @default.
• W2897592075 hasPrimaryLocation W28975920751 @default.
• W2897592075 hasRelatedWork W1980380624 @default.
• W2897592075 hasRelatedWork W1989512926 @default.

• next